Apply for the Creative Destruction Lab (CDL) Program

CDL-Berlin is located in Germany’s most vibrant startup ecosystem and hosted by ESMT Berlin, Germany’s #1 business school. By being deeply embedded in Germany’s deep tech economy, ESMT holds close ties with top-tier research institutions,…

More

Eckert & Ziegler Affiliate to Receive Multi-Million Euro Grant from the European Defense Fund for Development of Medical Countermeasures

 

BERLIN, GERMANY, August 04, 2022 – Myelo Therapeutics GmbH, an Affiliate of Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, SDAX) and member of a pan-European consortium of research and industry partners, was selected to…

More

International consortium including MDC brings together 7,200 segments of the human genome that are virtually unexplored

An international consortium brings together 7,200 segments of the human genome that are virtually unexplored and presents a roadmap for integrating them into genome databases in “Nature Biotechnology”. They could hold information about what sets…

More

SCIENION announces expansion in the UK with the opening of new R&D and manufacturing facilities

SCIENION’s UK operations to become global hub for contract manufacturing services

More

MDC researchers made a decisive step to therapeutic use of immunotherapy for blood cancer

Armin Rehm and Uta Höpken want to improve our immune defenses against cancer. They have recently shown in human cells what was previously only possible in mouse models. Their findings, published in "Molecular Therapy", have raised the chances of a…

More

MDC research team discovered how zebrafish can regenerate heart tissue

An MDC research team led by Jan Philipp Junker and Daniela Panáková has found that zebrafish can regenerate heart tissue after injury. Connective tissue cells play an important role in the process by temporarily entering an activated state, as the…

More

Eckert & Ziegler and PRECIRIX Sign Agreement on Priority Supply of the Therapeutic Radioisotope Actinium-225 (Ac-225)

 

Berlin, 20 July 2022. Eckert & Ziegler (ISIN DE0005659700, SDAX) and the Belgian biotech company PRECIRIX NV (PRECIRIX) have signed an agreement for the supply of Actinium-225. This gives PRECIRIX priority access to Eckert & Ziegler's high-purity,…

More

MDC researchers discovered how molecular boundaries across the genome work

The way the genome is folded regulates gene activation, so it can’t be left to chance. Molecular boundaries across the genome keep things in order. A team led by MDC researcher Darío Lupiáñez has discovered how these boundaries work. Their findings,…

More

LegoChem Biosciences and Glycotope announce research collaboration and license agreement for an antibody for use as antibody drug conjugate

 

Seoul, South Korea, and Berlin, Germany – (July 12, 2022) – LegoChem Biosciences Inc. (LCB) and Glycotope GmbH (Glycotope) have signed a Research Collaboration and License Agreement to develop an antibody drug conjugate (ADC) by combining LCB’s…

More

New Data at LINC 2022 Confirm Passeo-18 Lux Drug-Coated Balloon is a Safe and Effective Treatment in Challenging Patient Groups

Two presentations at LINC 2022 focus on the performance of BIOTRONIK’s drug-coated balloon as a standalone therapy or combined with selective stenting following suboptimal angioplasty in challenging femoropopliteal lesions

More
Show more items